EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mid-Regional Proadrenomedullin in COVID-19—May It Act as a Predictor of Prolonged Cardiovascular Complications?

Paulina Pietraszko iD, Marcin Zorawski iD, Emilia Bielecka, Piotr Sielatycki, Edyta Zbroch iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242316821 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paulina Pietraszko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-089 Bialystok, Poland. Hauptthemen laut MEDLINE: COVID-19, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising prevalence of cardiovascular disease (CVD) and the impact of the SARS-CoV-2 pandemic have both led to increased mortality rates, affecting public health and the global economy. Therefore, it is essential to find accessible, non-invasive prognostic markers capable of identifying patients at high risk. One encouraging avenue of exploration is the potential of mid-regional proadrenomedullin (MR-proADM) as a biomarker in various health conditions, especially in the context of CVD and COVID-19. MR-proADM presents the ability to predict mortality, heart failure, and adverse outcomes in CVD, offering promise for improved risk assessment and treatment strategies. On the other hand, an elevated MR-proADM level is associated with disease severity and cytokine storms in patients with COVID-19, making it a predictive indicator for intensive care unit admissions and mortality rates. Moreover, MR-proADM may have relevance in long COVID, aiding in the risk assessment, triage, and monitoring of individuals at increased risk of developing prolonged cardiac issues. Our review explores the potential of MR-proADM as a predictor of enduring cardiovascular complications following COVID-19 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cardiovascular DiseasesHumansPost-Acute COVID-19 SyndromeSARS-CoV-2BiomarkersAdrenomedullinProtein Precursors

Stichwörter der Autor:innen

COVID-19cardiovascular complicationscardiovascular diseaseslong-COVID-19mid-regional proadrenomedullin

Substanzen

BiomarkersAdrenomedullinproadrenomedullinProtein Precursors

Autor:innen und Institutionen

  • Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-089 Bialystok, Poland.

ORCID-Profile: Paulina Pietraszko, Marcin Zorawski, Edyta Zbroch

Zitieren

APA

Pietraszko, P., Zorawski, M., Bielecka, E., Sielatycki, P., & Zbroch, E. (2023). Mid-Regional Proadrenomedullin in COVID-19—May It Act as a Predictor of Prolonged Cardiovascular Complications?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316821

Vancouver

Pietraszko P, Zorawski M, Bielecka E, Sielatycki P, Zbroch E. Mid-Regional Proadrenomedullin in COVID-19—May It Act as a Predictor of Prolonged Cardiovascular Complications?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316821

BibTeX
@article{Pietraszko2023,
  author = {Pietraszko, Paulina and Zorawski, Marcin and Bielecka, Emilia and Sielatycki, Piotr and Zbroch, Edyta},
  title = {Mid-Regional Proadrenomedullin in COVID-19—May It Act as a Predictor of Prolonged Cardiovascular Complications?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242316821}
}
Kostenlos starten →